Skip to search formSkip to main contentSkip to account menu

Chimeric Antigen Receptor T-Cell Therapy

Known as: CAR T-cell therapy 
A type of treatment in which a patient's T cells (a type of immune system cell) are changed in the laboratory so they will attack cancer cells. T… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Extramedullary Multiple Myeloma Responds to Dual-Targeting CAR T-Cell Therapy
Chimeric antigen receptor T-cell therapy targeting both BCMA and CD38 induced an objective response in >90% of patients with… 
2019
2019
Promising Responses from Dual-Targeting CAR T-Cell Therapy in Myeloma Support Further Exploration
Chimeric antigen receptor T-cell therapy targeting both BCMA and CD38 induced an objective response in >90% of patients with… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)